List of Iovance Biotherapeutics patents

List of Iovance Biotherapeutics patents

List of Inbiomotion patents

List of Twist Bioscience patents

List of G1 Therapeutics patents

List of SBIR/STTR awards granted to LOGICAL SEMANTICS, INC.

List of companies in Swiss Post's investment portfolio

Patents where

Current Assignee

Name

is

Iovance Biotherapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells	Patent 11713446 was granted and assigned to Iovance Biotherapeutics on August, 2023 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11713446	August 1, 2023
	‌ US Patent 11631483 Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy	Patent 11631483 was granted and assigned to Iovance Biotherapeutics on April, 2023 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11631483	April 18, 2023
	‌ US Patent 11529372 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11529372 was granted and assigned to Iovance Biotherapeutics on December, 2022 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11529372	December 20, 2022
	‌ US Patent 11541077 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11541077 was granted and assigned to Iovance Biotherapeutics on January, 2023 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11541077	January 3, 2023
	‌ US Patent 11517592 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11517592 was granted and assigned to Iovance Biotherapeutics on December, 2022 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11517592	December 6, 2022
	‌ US Patent 11648278 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11648278 was granted and assigned to Iovance Biotherapeutics on May, 2023 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11648278	May 16, 2023
	‌ US Patent 11866688 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11866688 was granted and assigned to Iovance Biotherapeutics on January, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11866688	January 9, 2024
	‌ US Patent 11865140 Restimulation of cryopreserved tumor infiltrating lymphocytes	Patent 11865140 was granted and assigned to Iovance Biotherapeutics on January, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11865140	January 9, 2024
	‌ US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 12024718 was granted and assigned to Iovance Biotherapeutics on July, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	12024718	July 2, 2024
	‌ US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment	Patent 11981921 was granted and assigned to Iovance Biotherapeutics on May, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11981921	May 14, 2024
	‌ US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells	Patent 12104172 was granted and assigned to Iovance Biotherapeutics on October, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	12104172	October 1, 2024
	‌ US Patent 11975028 Restimulation of cryopreserved tumor infiltrating lymphocytes	Patent 11975028 was granted and assigned to Iovance Biotherapeutics on May, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11975028	May 7, 2024
	‌ US Patent 12121541 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 12121541 was granted and assigned to Iovance Biotherapeutics on October, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	12121541	October 22, 2024
	‌ US Patent 11667890 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion		Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11667890	June 6, 2023
	‌ US Patent 12023355 Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof	Patent 12023355 was granted and assigned to Iovance Biotherapeutics on July, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	12023355	July 2, 2024
	‌ US Patent 11857573 Restimulation of cryopreserved tumor infiltrating lymphocytes	Patent 11857573 was granted and assigned to Iovance Biotherapeutics on January, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11857573	January 2, 2024
	‌ US Patent 11998568 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11998568 was granted and assigned to Iovance Biotherapeutics on June, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11998568	June 4, 2024
	‌ US Patent 11939596 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy	Patent 11939596 was granted and assigned to Iovance Biotherapeutics on March, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11939596	March 26, 2024
	‌ US Patent 11969444 Restimulation of cryopreserved tumor infiltrating lymphocytes	Patent 11969444 was granted and assigned to Iovance Biotherapeutics on April, 2024 by the United States Patent and Trademark Office.	Iovance Biotherapeutics	Iovance Biotherapeutics		United States Patent and Trademark Office	11969444	April 30, 2024

19 results

0 selected

19 results

0 selected